Liver samples of NASH patients and rodent models of NASH showed increased expression of caspase 1, gasdermin D (GSDMD) and inflammasome components compared to the simple steatosis stage [98, 99]. This evidence concerns the gene GSDMD and metabolic dysfunction-associated steatohepatitis.